✦ LIBER ✦

S31 Mucosal healing in Crohn's disease is associated with high infliximab trough levels

✍ Scribed by W. Van Moerkercke; G. Compernolle; C. Ackaert; A. Gils; S. Vermeire; M. Jürgens; I. Cleynen; G. van Assche; P. Rutgeerts

Book ID: 119637688
Publisher: Oxford University Press
Year: 2010
Weight: 68 KB
Volume: 4
Category: Article
ISSN: 1873-9954
DOI: 10.1016/s1873-9954(10)70058-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

405 High Infliximab Trough Levels are As

405 High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease

✍ Wouter Van Moerkercke; Chloé Ackaert; Griet Compernolle; Matthias Jürgens; Isabe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Infliximab is Effective to Achieve Mucos

Infliximab is Effective to Achieve Mucosal Healing in Children With Crohn's Disease

✍ Kierkus, Jaroslaw ;Dadalski, Maciej ;Szymanska, Edyta ;Wegner, Agnieszka ;Oracz, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

P348 Serum infliximab levels and early m

P348 Serum infliximab levels and early mucosal healing in Crohn's disease

✍ Tang, J.; Gao, X.; Zhi, M.; Zhou, H.; Chen, H.; Zhang, M.; Yang, Q.; Liang, Z. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 136 KB

Infliximab trough levels may predict sus

Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease

✍ Bortlik, Martin; Duricova, Dana; Malickova, Karin; Machkova, Nadezda; Bouzkova, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 425 KB

919 Maintenance Q8 Therapy of Crohn's Di

919 Maintenance Q8 Therapy of Crohn's Disease with Infliximab Is Associated with Endoscopic Mucosal Healing in the Long-Term

✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Gert A. Van Assche; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Mucosal healing predicts long-term outco

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients